Bard Associates’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
20,007
-1,025
| -5% | -$58.6K | 0.37% | 83 |
|
|
2025
Q1 | $1.18M | Buy |
21,032
+1,002
| +5% | +$56.4K | 0.44% | 76 |
|
|
2024
Q4 | $1.24M | Buy |
20,030
+249
| +1% | +$15.4K | 0.42% | 77 |
|
|
2024
Q3 | $1.33M | Buy |
19,781
+224
| +1% | +$15.1K | 0.45% | 79 |
|
|
2024
Q2 | $1.31M | Buy |
19,557
+138
| +0.7% | +$9.26K | 0.5% | 73 |
|
|
2024
Q1 | $1.39M | Buy |
19,419
+1,390
| +8% | +$99.3K | 0.5% | 76 |
|
|
2023
Q4 | $1.52M | Sell |
18,029
-152
| -0.8% | -$12.8K | 0.58% | 65 |
|
|
2023
Q3 | $1.56M | Buy |
+18,181
| New | +$1.56M | 0.65% | 59 |
|